SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

Add CLDX Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 10/26/2016 2:48:34 PM - Followers: 97 - Board type: Free - Posts Today: 0






 Celldex Therapeutics, Inc. (CLDX)


Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
Product Pipeline:
News and Press Releases:
Events and Presentations:
SEC Filings:
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
Share Structure:
See SEC filings
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications






All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CLDX News: Phase 2 Study of Single-agent Glembatumumab Vedotin in Patients with Checkpoint-Refractory Metastatic Melanoma Meets Primary ... 10/09/2016 07:00:00 AM
CLDX News: Celldex Therapeutics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable 09/23/2016 11:30:00 AM
CLDX News: Statement of Changes in Beneficial Ownership (4) 09/07/2016 01:00:34 PM
CLDX News: Statement of Changes in Beneficial Ownership (4) 09/06/2016 01:05:10 PM
CLDX News: Initial Statement of Beneficial Ownership (3) 08/12/2016 07:59:32 AM
#1325   time for cldx to run! chart says its harry crumb 10/26/16 02:48:33 PM
#1324   Whats with the decline from $4.4s ?? HallaDurg 10/14/16 12:49:13 PM
#1323   matter of time for the pps to triple harry crumb 10/10/16 07:46:06 PM
#1322   Good data from phase 2 MakinBank 10/09/16 09:05:16 AM
#1321   Fill the gaps & reload... easy trader here... erehdogmai 10/07/16 02:22:15 PM
#1320   Hopefully Tim sykes Minions will jump in to Moto260 10/04/16 04:22:50 PM
#1319   Yes sir =D Moto260 10/04/16 03:59:54 PM
#1318   LOL. Short much?? ;) erehdogmai 10/04/16 02:45:15 PM
#1317   Breaking down lower and lower. $CLDX will Moto260 10/04/16 01:05:07 PM
#1316   Three Cancer Plays For The Fourth Quarter Of trendmkr 10/04/16 10:29:27 AM
#1315   Never holds gap ups well. RSI is Moto260 10/04/16 10:05:25 AM
#1314   thanx for posting. truly,, the phase 2 data harry crumb 10/04/16 09:51:30 AM
#1313   A phase 2 study of glembatumumab vedotin (GV), an koman 10/04/16 09:29:56 AM
#1312   next leg up on updates should take this harry crumb 10/03/16 10:37:00 AM
#1311   You may be right in that it appears 2014shelby 09/28/16 09:08:11 PM
#1310   OK we get it your short this stock. REDEMPTIVE 09/28/16 09:01:19 PM
#1309   CLDX in the 3's again. Seems like it's 2014shelby 09/28/16 03:26:52 PM
#1308   the pps should have never gone to where harry crumb 09/28/16 08:29:58 AM
#1307   Why the big move up today and why 2014shelby 09/27/16 05:32:38 PM
#1306   Definite burn on the shorts here. This is REDEMPTIVE 09/27/16 03:36:49 PM
#1305   soon to b over 5 again, go cldx, harry crumb 09/27/16 10:25:47 AM
#1304   Shorts may be in trouble? REDEMPTIVE 09/15/16 11:48:02 AM
#1303   Finally no clay!!!! Fightfordollar 09/07/16 08:09:08 PM
#1302   CLDX has been and will be volatile. I REDEMPTIVE 08/19/16 02:33:36 PM
#1301   CLDX doesn't look good today 2014shelby 08/19/16 12:47:28 PM
#1300   cldx looking good for upside moving forward. going harry crumb 08/09/16 01:31:02 PM
#1299   I've seen a lot of hold and buy 2014shelby 08/06/16 11:31:15 AM
#1298   What are thoughts on earnings on Monday? Thinking Spudskie 08/04/16 03:19:53 AM
#1297   CLDX has a great pipeline... REDEMPTIVE 08/03/16 12:55:31 PM
#1296   cldx will be 20+ again sooner than most harry crumb 07/28/16 11:54:44 PM
#1295   anyone else liking this chart? to me AXE2014 07/16/16 01:39:12 PM
#1294   HC, if your referring to the PR on 2014shelby 07/16/16 10:59:34 AM
#1293   read the news release harry crumb 07/16/16 10:38:30 AM
#1292   Which product are you referring to and is 2014shelby 07/16/16 10:00:40 AM
#1291   new product revealed, interesting pipeline that may just harry crumb 07/15/16 02:56:27 PM
#1290   i would assume they know some good things harry crumb 07/08/16 08:52:18 AM
#1289   Ok. What is your guess on the next 2014shelby 07/07/16 10:48:37 PM
#1288   no news since all the insiders bought stock. harry crumb 07/06/16 04:27:35 PM
#1287   4.25 buy again! harry crumb 07/04/16 12:46:44 AM
#1286   Timing this one may have made some good REDEMPTIVE 07/01/16 01:54:54 PM
#1285   out again 4.61-4.63 harry crumb 07/01/16 11:01:55 AM
#1284   You may be right. CLDX appears to be 2014shelby 06/30/16 10:52:46 PM
#1283   back in 4.26-4.35, looking for 4.80's for more profits harry crumb 06/29/16 06:32:29 PM
#1282   another flip for profits! harry crumb 06/20/16 10:37:08 AM
#1281   Good entry I'm hoping for 3.50-75 my money Lucky40 06/13/16 02:26:50 PM
#1280   added 3.99-4.03 harry crumb 06/13/16 01:23:22 PM
#1279   Waiting for lower might not happen Lucky40 06/13/16 11:53:36 AM
#1278   time to load up again, an flip! harry crumb 06/13/16 11:20:12 AM
#1277   Jumping in this stock once it breaks below $4 Lucky40 06/10/16 01:42:05 PM
#1276   Yes. Agreed. 2014shelby 06/10/16 11:14:48 AM